Common Stock, Shares, Outstanding of Sunshine Biopharma Inc. from 31 Dec 2010 to 30 Sep 2025

Taxonomy & unit
us-gaap: shares
Description
Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.
Summary
Sunshine Biopharma Inc. quarterly Common Stock, Shares, Outstanding in shares history and change rate from 31 Dec 2010 to 30 Sep 2025.
  • Sunshine Biopharma Inc. Common Stock, Shares, Outstanding for the quarter ending 30 Sep 2025 was 4,555,945, a 128% increase year-over-year.
Source SEC data
View on sec.gov
Common Stock, Shares, Outstanding, Quarterly (shares)
Common Stock, Shares, Outstanding, YoY Quarterly Change (%)

Sunshine Biopharma Inc. Quarterly Common Stock, Shares, Outstanding (shares)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q3 2025 4,555,945 +2,556,285 +128% 30 Sep 2025 10-Q 13 Nov 2025 2025 Q3
Q2 2025 4,555,945 +3,385,435 +289% 30 Jun 2025 10-Q 12 Aug 2025 2025 Q2
Q1 2025 2,707,541 +1,713,012 +172% 31 Mar 2025 10-Q 15 May 2025 2025 Q1
Q4 2024 2,580,098 +2,566,086 31 Dec 2024 10-Q 13 Nov 2025 2025 Q3
Q3 2024 1,999,660 -23,678,630 -92% 30 Sep 2024 10-Q 05 Nov 2024 2024 Q3
Q2 2024 1,170,510 -24,575,792 -95% 30 Jun 2024 10-Q/A 20 Aug 2024 2024 Q2
Q1 2024 994,529 -21,145,392 -96% 31 Mar 2024 10-Q 20 May 2024 2024 Q1
Q4 2023 14,012* -22,571,620 31 Dec 2023 10-K 01 Apr 2025 2024 FY
Q3 2023 25,678,290 +6,792,658 +36% 30 Sep 2023 10-Q 13 Nov 2023 2023 Q3
Q2 2023 25,746,302 +6,860,670 +36% 30 Jun 2023 10-Q 10 Aug 2023 2023 Q2
Q1 2023 22,139,921 +14,990,143 +210% 31 Mar 2023 10-Q 10 May 2023 2023 Q1
Q4 2022 22,585,632 +19,994,392 +772% 31 Dec 2022 10-K 28 Mar 2024 2023 FY
Q3 2022 18,885,632 -491,207,633 -96% 30 Sep 2022 10-Q 07 Nov 2022 2022 Q3
Q2 2022 18,885,632 -467,207,633 -96% 30 Jun 2022 10-Q 03 Aug 2022 2022 Q2
Q1 2022 7,149,778 -457,856,147 -98% 31 Mar 2022 10-Q 06 May 2022 2022 Q1
Q4 2021 2,591,240 +859,144 +50% 31 Dec 2021 10-K 04 Apr 2023 2022 FY
Q3 2021 510,093,265 +205,673,969 +68% 30 Sep 2021 10-Q 09 Nov 2021 2021 Q3
Q2 2021 486,093,265 +216,272,017 +80% 30 Jun 2021 10-Q 09 Aug 2021 2021 Q2
Q1 2021 465,005,925 +405,330,508 +679% 31 Mar 2021 10-Q 11 May 2021 2021 Q1
Q4 2020 1,732,096 -33,587,894 -95% 31 Dec 2020 10-K 21 Mar 2022 2021 FY
Q3 2020 304,419,296 -7,006,764 -2.2% 30 Sep 2020 10-Q 12 Nov 2020 2020 Q3
Q2 2020 269,821,248 +165,533,827 +159% 30 Jun 2020 10-Q/A 31 Aug 2020 2020 Q2
Q1 2020 59,675,417 -29,673,564 -33% 31 Mar 2020 10-Q 18 May 2020 2020 Q1
Q4 2019 35,319,990 +31,037,370 +725% 31 Dec 2019 10-K 30 Mar 2021 2020 FY
Q3 2019 311,426,060 -1,274,202,434 -80% 30 Sep 2019 10-Q 13 Nov 2019 2019 Q3
Q2 2019 104,287,421 -999,818,385 -91% 30 Jun 2019 10-Q 15 Aug 2019 2019 Q2
Q1 2019 89,348,981 -859,670,551 -91% 31 Mar 2019 10-Q 20 May 2019 2019 Q1
Q4 2018 4,282,620 -41,654,205 -91% 31 Dec 2018 10-K 01 May 2020 2019 FY
Q3 2018 1,585,628,494 +666,891,996 +73% 30 Sep 2018 10-Q 16 Nov 2018 2018 Q3
Q2 2018 1,104,105,806 +235,511,156 +27% 30 Jun 2018 10-Q 17 Aug 2018 2018 Q2
Q1 2018 949,019,532 +131,091,549 +16% 31 Mar 2018 10-Q 22 May 2018 2018 Q1
Q4 2017 45,936,825 -723,463,033 -94% 31 Dec 2017 10-K 12 Apr 2019 2018 FY
Q3 2017 918,736,498 +282,711,115 +44% 30 Sep 2017 10-Q 15 Nov 2017 2017 Q3
Q2 2017 868,594,650 +594,162,741 +217% 30 Jun 2017 10-Q 11 Aug 2017 2017 Q2
Q1 2017 817,927,983 +585,051,630 +251% 31 Mar 2017 10-Q 12 May 2017 2017 Q1
Q4 2016 769,399,858 +571,134,740 +288% 31 Dec 2016 10-K 02 Apr 2018 2017 FY
Q3 2016 636,025,383 +501,633,286 +373% 30 Sep 2016 10-Q 14 Nov 2016 2016 Q3
Q2 2016 274,431,909 +147,959,459 +117% 30 Jun 2016 10-Q 16 Aug 2016 2016 Q2
Q1 2016 232,876,353 +130,430,016 +127% 31 Mar 2016 10-Q 09 May 2016 2016 Q1
Q4 2015 198,265,118 +124,714,077 +170% 31 Dec 2015 10-K 17 Apr 2017 2016 FY
Q3 2015 134,392,097 +65,481,056 +95% 30 Sep 2015 10-Q 04 Nov 2015 2015 Q3
Q2 2015 126,472,450 +60,506,722 +92% 30 Jun 2015 10-Q 06 Aug 2015 2015 Q2
Q1 2015 102,446,337 +39,770,609 +63% 31 Mar 2015 10-Q 07 May 2015 2015 Q1
Q4 2014 73,551,041 +13,251,980 +22% 31 Dec 2014 10-K 25 Mar 2016 2015 FY
Q3 2014 68,911,041 +12,071,980 +21% 30 Sep 2014 10-Q 12 Nov 2014 2014 Q3
Q2 2014 65,965,728 +9,526,667 +17% 30 Jun 2014 10-Q 12 Aug 2014 2014 Q2
Q1 2014 62,675,728 +6,486,667 +12% 31 Mar 2014 10-Q 09 May 2014 2014 Q1
Q4 2013 60,299,061 +8,882,969 +17% 31 Dec 2013 10-K 11 Mar 2015 2014 FY
Q3 2013 56,839,061 +5,447,969 +11% 30 Sep 2013 10-Q 04 Nov 2013 2013 Q3
Q2 2013 56,439,061 +7,230,219 +15% 30 Jun 2013 10-Q 06 Aug 2013 2013 Q2
Q1 2013 56,189,061 +7,460,219 +15% 31 Mar 2013 10-Q 09 May 2013 2013 Q1
Q4 2012 51,416,092 +2,687,250 +5.5% 31 Dec 2012 10-K 19 Mar 2014 2013 FY
Q3 2012 51,391,092 +20,353,750 +66% 30 Sep 2012 10-Q 08 Nov 2012 2012 Q3
Q2 2012 49,208,842 +18,497,500 +60% 30 Jun 2012 10-Q 08 Aug 2012 2012 Q2
Q1 2012 48,728,842 +18,017,500 +59% 31 Mar 2012 10-Q 08 May 2012 2012 Q1
Q4 2011 48,728,842 +18,037,500 +59% 31 Dec 2011 10-K 15 Mar 2013 2012 FY
Q3 2011 31,037,342 30 Sep 2011 10-Q 08 Nov 2011 2011 Q3
Q2 2011 30,711,342 30 Jun 2011 10-Q 09 Aug 2011 2011 Q2
Q1 2011 30,711,342 31 Mar 2011 10-Q 12 May 2011 2011 Q1
Q4 2010 30,691,342 31 Dec 2010 10-K 19 Mar 2012 2011 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.